Funded equally by LUNGevity Foundation and American Lung Association National Office
Matthew Meyerson, MD, PhD
Dana-Farber Cancer Institute
Boston
Dr. Meyerson is exploring how a mutation in the EGFR cells can lead to cancer as well as what the mechanisms are for acquired resistance to EGFR therapies.